Petr F. Kuzma, VP, Research and Development at Valera Pharmaceuticals Inc (VLRX), bought 1,100 shares at $9.00 ($10K) on 2006-02-02, disclosed to the SEC on 2006-02-02.
Open-market purchase of $10k VLRX by VP, Research and Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.